XML 65 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Warrant Liabilities - Schedule of Outstanding Warrants Liabilities (Details) (10-K) - $ / shares
 6 Months Ended 12 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Dec. 31, 2016
Series A (2011) [Member]      
Number of Warrant Outstanding, shares [1]   4,327
Warrant Exercise Price, Per Share [1]   $ 2,244.00  
Warrant Exercisable [1]    
Number of Warrant Exercisable, Period   December 2016  
Series A (2013) [Member]      
Number of Warrant Outstanding, shares [1] 3,895 3,895 3,895
Warrant Exercise Price, Per Share $ 2,885.00 $ 2,885.00 [1]  
Warrant Exercisable [1] 3,895 3,895  
Number of Warrant Exercisable, Period October 2018 October 2018  
Series A (2013) [Member]      
Number of Warrant Outstanding, shares [1] 183 183 183
Warrant Exercise Price, Per Share $ 2,725.00 $ 2,725.00 [1]  
Warrant Exercisable [1] 183 183  
Number of Warrant Exercisable, Period April 2023 April 2023  
Series A (2015) [Member]      
Number of Warrant Outstanding, shares [1] 683 683 683
Warrant Exercise Price, Per Share $ 1,363.00 $ 1,363.00 [1]  
Warrant Exercisable [1] 683 683  
Number of Warrant Exercisable, Period April 2020 April 2020  
Series A (2016) [Member]      
Number of Warrant Outstanding, shares [1] [2] 625 [3] 677 [3]
Warrant Exercise Price, Per Share [2] $ 40.00 [1],[3]  
Warrant Exercisable [1] [2] 625 [3]  
Number of Warrant Exercisable, Period March 2018 [2] March 2018 [3]  
Series B (2016) [Member]      
Number of Warrant Outstanding, shares [1] 2,770 [2] 2,770 [3] 2,770 [3]
Warrant Exercise Price, Per Share $ 40.00 [2] $ 40.00 [1],[3]  
Warrant Exercisable [1] 2,770 [2] 2,770 [3]  
Number of Warrant Exercisable, Period March 2022 [2] March 2022 [3]  
[1] December 31 2017 and 2016 warrants data represents the number of shares adjusted to retroactively reflect the 1:15 Reverse Split effected on September 4, 2018.
[2] These warrants contain a full ratchet anti-dilution price protection so that, in most situations upon the issuance of any common stock or securities convertible into common stock at a price below the then-existing exercise price of the outstanding warrants, the warrant exercise price will be reset to the lower common stock sales price. As such anti-dilution price protection does not meet the specific conditions for equity classification, the Company is required to classify the fair value of these warrants as a liability, with changes in fair value to be recorded as income (loss) due to change in fair value of warrant liability. The estimated fair value of our warrant liability at June 30, 2018 and December 31, 2017, was approximately $14 and $28, respectively.
[3] These warrants contain a full ratchet anti-dilution price protection so that, in most situations upon the issuance of any common stock or securities convertible into common stock at a price below the then-existing exercise price of the outstanding warrants, the warrant exercise price will be reset to the lower common stock sales price. As such anti-dilution price protection does not meet the specific conditions for equity classification, the Company is required to classify the fair value of these warrants as a liability, with changes in fair value to be recorded as income (loss) due to change in fair value of warrant liability. The estimated fair value of our warrant liability at December 31, 2017 and December 31, 2016, was approximately $28 and $313, respectively.